Browse the corpus

REFERENCES American Academy of Pediatrics Committee on Drugs, "Transfer of Drugs and Other Chemicals Into Human Milk,” Pediatrics , 2001, 108(3): 776-89. [PubMed 11533352 ] Bennie RE, Boehringer LA, Dierdorf SF, et al, “Transnasal Butorphanol Is Effective for Postoperative Pain Relief in Children Undergoing Myringotomy,” Anesthesiology , 1998, 89(2):385-90. [PubMed 9710397 ] Commiskey S, Fan LW, Ho IK, et al, “Butorphanol: Effects of a Prototypical Agonist-Antagonist Analgesic on Kappa-Opioid Receptors,” J Pharmacol Sci , 2005, 98(2):109-16. [PubMed 15942128 ] “Drugs for Pain,” Med Lett Drugs Ther , 2000, 42(1085):73-8. [PubMed 10951654 ] Gaver RC, Vasiljev M, Wong H, et al, “Disposition of Parenteral Butorphanol in Man,” Drug Metab Dispos , 1980, 8(4):230-5. [PubMed 6105056 ] Melanson SW, Morse JW, Pronchik DJ, et al, “Transnasal Butorphanol in the Emergency Department Management of Migraine Headache,” Am J Emerg Med , 1997, 15(1):57-61. [PubMed 9002572 ] Mokhlesi B, Leikin JB, Murray P, et al, “Adult Toxicology in Critical Care: Part II: Specific Poisonings,” Chest , 2003, 123(3):897-922. [PubMed 12628894 ] Nelson KE and Eisenach JC, “Intravenous Butorphanol, Meperidine, and Their Combination Relieve Pain and Distress in Women in Labor,” Anesthesiology , 2005, 102(5):1008-13. [PubMed 15851889 ] Pachter IJ and Evens RP, “Butorphanol,” Drug Alcohol Depend , 1985, 14(3-4):325-38. [PubMed 3888579 ] “Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain,” 6th ed, Glenview, IL: American Pain Society, 2008. Ramsey R, Higbee M, Maesner J, et al, “Influence of Age on the Pharmacokinetics of Butorphanol,” Acute Care , 1986, 12(Suppl 1):8-16. [PubMed 3344601 ] Shyu WC, Morgenthien EA, and Barbhaiya RH, “Pharmacokinetics of Butorphanol Nasal Spray in Patients With Renal Impairment,” Br J Clin Pharmacol , 1996, 41(5):397-402. [PubMed 8735680 ] Srinivas NR, Shyu WC, Upmalis D, et al, “Lack of Pharmacokinetic Interaction Between Butorphanol Tartrate Nasal Spray and Sumatriptan Succinate,” J Clin Pharmacol , 1995, 35(4):432-7. [PubMed 7650235 ] Vachharajani NN, Shyu WC, Garnett WR, et al, “The Absolute Bioavailability and Pharmacokinetics of Butorphanol Nasal Spray in Patients With Hepatic Impairment,” Clin Pharmacol Ther , 1996, 60(3):283-94. [PubMed 8841151 ]

Srinivas NR, Shyu WC, Upmalis D, et al, “Lack of Pharmacokinetic Interaction Between Butorphanol Tartrate Nasal Spray and Sumatriptan Succinate,” J Clin Pharmacol , 1995, 35(4):432-7. [PubMed 7650235 ] Vachharajani NN, Shyu WC, Garnett WR, et al, “The Absolute Bioavailability and Pharmacokinetics of Butorphanol Nasal Spray in Patients With Hepatic Impairment,” Clin Pharmacol Ther , 1996, 60(3):283-94. [PubMed 8841151 ] Vachharajani NN, Shyu WC, Greene DS, et al, “The Pharmacokinetics of Butorphanol and Its Metabolites at Steady State Following Nasal Administration in Humans,” Biopharm Drug Dispos , 1997, 18(3):191-202. [PubMed 9113342 ] Topic 9179 Version 43.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [1004-118.195.65.247-FCC50AAECF-S244013.14]